Skip to main content

A worldwide technology outage is causing disruption to some State of Illinois online systems. We are aware of this issue and are diligently working on restoration.

Notice of Privacy Incident
We are offering two in-person Healthchoice Illinois Listening Sessions allow you the opportunity to talk about your experiences with HealthChoice Illinois managed care. Please be sure to register for one of these important events.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: March 16, 2016

Drug Name	Review Type	Class	Manufacturer
Prezcobix	New Drug Initial Review	HIV	Johnson & Johnson
Envarsus XR	New Drug Initial Review	Immunosupressant	Veloxis Pharmaceuticals
Nucala	New Drug Initial Review	Severe Asthma	Glaxo Smith Kline
Zomacton	New Drug Initial Review	Growth Hormone	Ferring Pharmaceuticals
Veltassa	New Drug Initial Review	Potassium Binder	Relypsa, Inc.
Zepatier	New Drug initial Review	Hepatitis C	Merck
Jadenu	New Drug Appeal	Iron Chelator	Novartis
Triumeq	New Drug Appeal	HIV	ViiV Healthcare
Kitabis	New Drug Appeal	Cystic Fibrosis	Pari Respiratory, Inc.
Invega Trinza	New Drug Appeal	Long Acting Antipsychotic	Johnson & Johnson